The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

World News

McKinsey & Co. to pay $650M to settle opioid consulting probe, ex-partner to plead guilty

by admin December 17, 2024
December 17, 2024
McKinsey & Co. to pay $650M to settle opioid consulting probe, ex-partner to plead guilty

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to increase sales of its opioid painkiller OxyContin, a court filing said Friday.

A former top partner at McKinsey, Martin Elling, also agreed to plead guilty to obstruction of justice next month in the probe by the U.S. Department of Justice, according to a filing in U.S. District Court in Abingdon, Virginia.

The criminal charging document that McKinsey agreed to have filed by prosecutors alleges the consulting giant “knowingly and intentionally” conspired with Purdue Pharma “and others to aid and abet the misbranding of prescription drugs.”

The document also said McKinsey is accused, through the acts of its then-partner Elling, of “knowingly destroying and concealing records and documents with the intent” to impede the investigation by the Department of Justice.

McKinsey, which previously agreed to pay almost $1 billion to settle lawsuits by states, local governments and others related to its opioid consulting, accepted responsibility for the conduct alleged by federal prosecutors, according to the deferred prosecution agreement.

As part of the deal, McKinsey will not work on any marketing, sale, promotion or distribution of controlled substances.

In a statement to CNBC, McKinsey said, “We are deeply sorry for our past client service to Purdue Pharma and the actions of a former partner who deleted documents related to his work for that client.”

“We should have appreciated the harm opioids were causing in our society and we should not have undertaken sales and marketing work for Purdue Pharma,” the firm said. “This terrible public health crisis and our past work for opioid manufacturers will always be a source of profound regret for our firm has requested comment from McKinsey.”

The company said that in addition to its deferred prosecution agreement with the DOJ, it “has agreed to settle a related civil False Claims Act investigation and to enter into a Corporate Integrity Agreement with the Office of Inspector General at the Department of Health and Human Services.”

This post appeared first on NBC NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Trump and Japan tech conglomerate SoftBank announce $100 billion in U.S. investments
next post
Walmart employees are now wearing body cameras in some U.S. stores

Related Posts

Ad revenue should stabilize for media companies in...

December 31, 2024

JPMorgan Chase is giving its employees an AI...

August 12, 2024

Trump clears Nippon merger with U.S. Steel

May 24, 2025

Temple University reviewing reports of potential match-fixing of...

March 9, 2024

Tesla investors want Elon Musk to answer questions...

January 30, 2025

Trump implies government could cut contracts and subsidies...

June 8, 2025

U.S. judge orders Google to share search data...

September 3, 2025

Hooters to close ‘underperforming’ restaurants amid broader industry...

June 27, 2024

U.S. could take stakes in more firms, White...

August 26, 2025

What’s Turo? The ‘Airbnb of cars’ was used...

January 4, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Ben & Jerry’s co-founder resigns, claiming parent company Unilever ‘silenced’ its campaigning

      September 20, 2025
    • The Real Drivers of This Market: AI, Semis & Robotics

      September 20, 2025
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      September 20, 2025
    • 58 House Dems vote against resolution honoring ‘life and legacy’ of Charlie Kirk

      September 20, 2025
    • Trump-approved plan to avert government shutdown scuttled by Senate

      September 20, 2025
    • Senate Republicans block Democrats’ ‘filthy’ counteroffer as shutdown deadline looms

      September 20, 2025

    Categories

    • Business (1,387)
    • Politics (4,534)
    • Stocks (1,659)
    • Uncategorized (45)
    • World News (1,380)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved